Tonix Pharmaceuticals (NASDAQ: TNXP) will implement a 1-for-100 reverse stock split, effective at <a target=_blank href= ...

CHATHAM, N.J. - Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP), a biopharmaceutical company, has announced a 1-for-100 reverse stock split of its common stock, set to take effect as trading opens ...

CHATHAM, N.J., Feb. 03, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: TNXP) (Tonix or the Company), a fully-integrated biopharmaceutical ...

SAN DIEGO, CALIFORNIA / ACCESS Newswire / January 29, 2025 / Cubic Corporation announces that its Microelectronics business, Nuvotronics, has been selected by MDA Space Ltd. (TSX:MDA), a leading provi ...

While acknowledging that the evaluation of the bids was done in line with the process, the regulator said, "SECI should have been more careful in adhering to the timelines." In its appeal, JSW Renew ...

The US ambassador to India emphasized the need for India to reduce high tariffs to attract investment and compete with Southeast Asia amidst escalating US-China trade tensions. Despite some progress, ...

Washing labels aren't always the most straightforward to read, and if you don't know what they mean you could end up ruining your clothes. Thankfully the symbols they use are (mostly) universal, so ...

However, getting an overdraft approved is not always easy, and sometimes you may face rejection or reduction of your overdraft limit. This can be frustrating and stressful, especially if you rely ...

I maintain a "strong sell" rating on AVXL, anticipating a significant stock drop after likely EMA rejection of blarcamesine later this year. In a 48-week Phase 2b/3 study, blarcamesine ...

The hunt for Roki Sasaki is over, which likely means most of the drama around the Yankees rotation is over for the rest of the offseason. After Sasaki rejected the Yankees on Monday, the club’s ...

Everyone experiences rejection at one time or another. It's a normal part of life. However, for people with rejection sensitive dysphoria (RSD), even mild rejection can lead to intense and ...